A Randomized Controlled Trial to Assess Sunscreen Application and Beta Carotene Supplementation in the Prevention of Solar Keratoses | Cancer Screening, Prevention, Control | JAMA Dermatology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Staples  MMarks  RGiles  G Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect?  Int J Cancer. 1998;78144- 148Google ScholarCrossref
Miller  DLWeinstock  MA Nonmelanoma skin cancer in the United States: incidence.  J Am Acad Dermatol. 1994;30774- 778Google ScholarCrossref
Levi  FErler  GTe  VCRandimbison  LLa Vecchia  C Trends in skin cancer incidence in Neuchatel, 1976-98.  Tumori. 2001;87288- 289Google Scholar
Green  ABattistutta  DHart  VLeslie  DWeedon  Dfor the Nambour Study Group, Skin cancer in a subtropical Australian population: incidence and lack of association with occupation.  Am J Epidemiol. 1996;1441034- 1040Google ScholarCrossref
Marks  RRennie  GSelwood  TS Malignant transformation of solar keratoses to squamous cell carcinoma.  Lancet. 1988;1795- 797Google ScholarCrossref
Frost  CWilliams  GGreen  A High incidence and regression rates of solar keratoses in a Queensland community.  J Invest Dermatol. 2000;115273- 277Google ScholarCrossref
Thompson  SCJolley  DMarks  R Reduction of solar keratoses by regular sunscreen use.  N Engl J Med. 1993;3291147- 1151Google ScholarCrossref
Naylor  MFBoyd  FASmith  DWCameron  GSHubbard  DNeldner  KH High sun protection factor sunscreens in the suppression of actinic neoplasia.  Arch Dermatol. 1995;131170- 175Google ScholarCrossref
Black  HSHerd  JAGoldberg  LH  et al.  Effect of a low-fat diet on the incidence of actinic keratosis.  N Engl J Med. 1994;3301272- 1275Google ScholarCrossref
Mathews-Roth  MMKrinsky  NI Carotenoids affect development of UV-B induced skin cancer.  Photochem Photobiol. 1987;46507- 509Google ScholarCrossref
Lambert  LAWamer  WGWei  RRLavu  SChirtel  SJKornhauser  A The protective but nonsynergistic effect of dietary beta-carotene and vitamin E on skin tumorigenesis in Skh mice.  Nutr Cancer. 1994;211- 12Google ScholarCrossref
Green  AWilliams  GNeale  R  et al.  Daily sunscreen application and beta-carotene supplementation in prevention of BCC and SCC of the skin: a randomised controlled trial.  Lancet. 1999;354723- 729Google ScholarCrossref
Green  ABattistutta  DHart  V  et al.  The Nambour skin cancer and actinic eye disease prevention trial: design and baseline characteristics of participants.  Control Clin Trials. 1994;15512- 522Google ScholarCrossref
Mathews-Roth  MPathak  UFitzpatrick  THarber  LKass  E Beta-carotene as an oral photoprotective agent in erythropoietic protoporphyria.  JAMA. 1974;2281004- 1008Google ScholarCrossref
Leventhal  HNerenz  DRLeventhal  EALove  RRBendena  LM The behavioral dynamics of clinical trials.  Prev Med. 1991;20132- 146Google ScholarCrossref
April 2003

A Randomized Controlled Trial to Assess Sunscreen Application and Beta Carotene Supplementation in the Prevention of Solar Keratoses

Author Affiliations

From the Comprehensive Cancer Research Center, Population and Clinical Sciences Division, Queensland Institute of Medical Research (Mr Darlington and Drs Neale, Frost, and Green), and the School of Population Health, University of Queensland, Australia (Dr Williams). The authors have no relevant financial interest in this article.

Arch Dermatol. 2003;139(4):451-455. doi:10.1001/archderm.139.4.451

Background  Solar keratoses (SKs) are among the strongest determinants of skin cancer, but little is known about the success of measures to control these common skin tumors.

Objective  To determine whether daily sunscreen application and/or beta carotene supplementation retards the rate of occurrence of SKs in adults in the medium term.

Design  Randomized controlled trial conducted between February 1992 and August 1996.

Setting  General community of the subtropical township of Nambour, Australia (latitude, 26° south).

Participants  A total of 1621 adults aged 25 to 74 years.

Interventions  Participants were randomized to daily use of sunscreen (application of a high-protection sunscreen to their head, neck, arms, and hands every morning) or application of sunscreen at their usual discretionary rate. They were also randomly assigned to take either one 30-mg tablet of beta carotene or one placebo tablet each day.

Main Outcome Measure  Change in the prevalent number of SKs in the intervention group relative to change in the control group.

Results  The ratio of SK counts in 1994 relative to 1992 was lower in people randomized to daily sunscreen use (1.20; 95% confidence interval, 1.04-1.39) than in those randomized to discretionary sunscreen use (1.57; 95% confidence interval, 1.35-1.84). This 24% reduction is equivalent to the prevention of an average of 1 additional SK per person over that time. A reduction in the rate of change of SK prevalence was also seen in the sunscreen intervention group relative to the discretionary sunscreen group between 1994 and 1996, but it was not significant. No effect on the rate of change of prevalent SK counts was seen among those taking beta carotene supplements relative to those taking placebo tablets.

Conclusions  Daily application of sunscreen retarded the rate of SK acquisition among adults in a subtropical environment, while a beta carotene supplementation of 30 mg/d had no influence on the occurrence of SKs.